Corrigendum to "Hepatocellular carcinoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255
| Errataetall: |
ErratumFor: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. - PMID 30285213 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 33(2022), 6 vom: 26. Juni, Seite 666 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vogel, A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 02.06.2022 published: Print-Electronic ErratumFor: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. - PMID 30285213 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.annonc.2022.03.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338952764 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338952764 | ||
| 003 | DE-627 | ||
| 005 | 20231226001826.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2022.03.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1129.xml |
| 035 | |a (DE-627)NLM338952764 | ||
| 035 | |a (NLM)35365377 | ||
| 035 | |a (PII)S0923-7534(22)00387-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vogel, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Hepatocellular carcinoma |b ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.06.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. - PMID 30285213 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Cervantes, A |e verfasserin |4 aut | |
| 700 | 1 | |a Chau, I |e verfasserin |4 aut | |
| 700 | 1 | |a Daniele, B |e verfasserin |4 aut | |
| 700 | 1 | |a Llovet, J M |e verfasserin |4 aut | |
| 700 | 1 | |a Meyer, T |e verfasserin |4 aut | |
| 700 | 1 | |a Nault, J-C |e verfasserin |4 aut | |
| 700 | 1 | |a Neumann, U |e verfasserin |4 aut | |
| 700 | 1 | |a Ricke, J |e verfasserin |4 aut | |
| 700 | 1 | |a Sangro, B |e verfasserin |4 aut | |
| 700 | 1 | |a Schirmacher, P |e verfasserin |4 aut | |
| 700 | 1 | |a Verslype, C |e verfasserin |4 aut | |
| 700 | 1 | |a Zech, C J |e verfasserin |4 aut | |
| 700 | 1 | |a Arnold, D |e verfasserin |4 aut | |
| 700 | 1 | |a Martinelli, E |e verfasserin |4 aut | |
| 700 | 0 | |a ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 33(2022), 6 vom: 26. Juni, Seite 666 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2022 |g number:6 |g day:26 |g month:06 |g pages:666 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annonc.2022.03.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2022 |e 6 |b 26 |c 06 |h 666 | ||